HCPLive

Prenatal Vitamin C Cuts Wheeze in Babies of Smokers

MONDAY, May 6 (HealthDay News) -- For women who smoke, vitamin C supplementation during pregnancy is associated with reduced incidence of wheezing in their offspring through the age of 1 year, according to a study presented at the annual meeting of the Pediatric Academic Societies, held from May 4 to 7 in Washington, DC.

Cindy T. McEvoy, MD, from the Oregon Health & Science University, in Portland, and colleagues examined the impact of supplemental daily vitamin C during pregnancy on the incidence of wheezing within the first year of life. The infants of 76 smokers randomized to vitamin C, the infants of 83 smokers randomized to placebo, and the infants of 76 nonsmokers were assessed at delivery. Ninety-two percent were followed through age 1.

The researchers found that significantly fewer infants of vitamin-C treated versus placebo-treated smokers had at least one episode of wheezing (21 versus 40 percent; adjusted P = 0.019) and fewer infants received medication for wheezing (13 versus 22 percent; adjusted P = 0.14). The incidence of wheezing was significantly lower for those randomized to vitamin C versus placebo for infants of pregnant smokers homozygous or heterozygous for the rs16969968 risk allele (14 versus 48 percent; P = 0.01).

"Vitamin C is a simple, safe, and inexpensive treatment that may decrease the impact of smoking during pregnancy on childhood respiratory health," McEvoy said in a statement. "Though the lung function of all babies born to smokers in our study was improved by supplemental vitamin C, our preliminary data suggest that vitamin C appeared to help those babies at the greatest risk of harm during their development from their mother's smoking in pregnancy."

Press Release
More Information

Copyright © 2013 HealthDay. All rights reserved.

Most Popular

Recommended Reading

The US Food and Drug Administration (FDA) on Thursday approved Orkambi (lumacaftor/ivacaftor/Vertex) to treat cystic fibrosis patients age 12 and older with two copies of the F508del mutation in the CFTR gene.
Michigan State University (MSU) researchers have created the first map to predict rotavirus (RV) prevalence on a global scale.
Discontinuation of multiple sclerosis medication saw nearly 2 in 5 patients experience some form of increased disease activity, according to research from NYU Langone Medical Center.
A novel virus from Peru and the Republic of Congo called enterovirus C105 is now suspected in last year's wave of mysterious cases of sudden childhood paralysis.
$vAR$